MEGAN FONTENOT: Open Payments
NPI 1144991043 · CARENCRO, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 53 payments from 19 companies in 2025. Trend: 2023 $619 · 2024 $1,158 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $172 |
| ABBVIE INC. | 5 | $104 |
| Kowa Pharmaceuticals America, Inc. | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Lilly USA, LLC | 4 | $78 |
| Sumitomo Pharma America, Inc. | 3 | $72 |
| Novo Nordisk Inc | 4 | $66 |
| PFIZER INC. | 4 | $65 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Axsome Therapeutics, Inc. | 2 | $51 |
Products named: AIRSUPRA, ZORYVE, TRINTELLIX, GEMTESA, VRAYLAR, TRELEGY ELLIPTA, Auvelity, UBRELVY.
Industry payments across LA — which companies pay providers there.
